Laekna Seeks HK$230 Million in Placement Deal; Shares Fall 9%
MT Newswires Live2024-11-21
Laekna (HKG:2105) will sell 17,636,000 new shares to at least six investors under a placing deal, according to a Thursday filing with the Hong Kong Exchange.
The biotechnology company will shell the shares at HK$13.36 apiece.
The shares represent 4.33% of Laekna's issued share capital, as enlarged by the placement.
Net proceeds, estimated at HK$230.3 million, will be used to speed up research for the company's LAE102 weight-loss drug, the filing stated.
Shares slid 9% during Thursday's morning trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
